Related references
Note: Only part of the references are listed.The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy?
Shunchuan Zhang et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Michael Weller et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Matthias Gromeier et al.
NATURE COMMUNICATIONS (2021)
A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
Fadi Jacob et al.
CELL (2020)
Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus
Sarah Aref et al.
MOLECULAR THERAPY (2020)
Developing oncolytic viruses for clinical use: A consortium approach
Vera Kemp et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Application of microfluidic devices for glioblastoma study: current status and future directions
Xue Cai et al.
BIOMEDICAL MICRODEVICES (2020)
Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma
William P. Accomando et al.
CLINICAL CANCER RESEARCH (2020)
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma A Randomized Clinical Trial
Timothy F. Cloughesy et al.
JAMA ONCOLOGY (2020)
Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus
Guendalina Froechlich et al.
CANCERS (2020)
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
Niklas Schaefer et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism
Johann Foloppe et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Shared and Distinct Functions of Type I and Type III Interferons
Helen M. Lazear et al.
IMMUNITY (2019)
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
Maisa C. Takenaka et al.
NATURE NEUROSCIENCE (2019)
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
Praveen K. Bommareddy et al.
ONCOIMMUNOLOGY (2019)
STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
Xiaoyan Shao et al.
FRONTIERS IN ONCOLOGY (2019)
Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery
Philip C. De Witt Hamer et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance
Stacie K. Totsch et al.
ONCOGENE (2019)
Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas
Alexandros Papachristodoulou et al.
CLINICAL CANCER RESEARCH (2019)
Experimental models and tools to tackle glioblastoma
Faye L. Robertson et al.
DISEASE MODELS & MECHANISMS (2019)
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Olivia G. Taylor et al.
FRONTIERS IN ONCOLOGY (2019)
Nogo receptor-vimentin interaction: a novel mechanism for the invasive activity of glioblastoma multiforme
Yun Hee Kang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
3D extracellular matrix microenvironment in bioengineered tissue models of primary pediatric and adult brain tumors
Disha Sood et al.
NATURE COMMUNICATIONS (2019)
Immune landscapes associated with different glioblastoma molecular subtypes
Maria Martinez-Lage et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model
Norihiko Saito et al.
CANCERS (2019)
Intracellular sensing of viral genomes and viral evasion
Hyun-Cheol Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
E. Antonio Chiocca et al.
NEURO-ONCOLOGY (2019)
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Mapping the preclinical to clinical evidence and development trajectory of the oncolytic virus talimogene laherparepvec (T-VEC): a systematic review
Manoj Lalu et al.
BMJ OPEN (2019)
Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
Volker Schirrmacher et al.
BIOMEDICINES (2019)
Implementing TMB measurement in clinical practice: considerations on assay requirements
Reinhard Buettner et al.
ESMO OPEN (2019)
Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype
M. D. Sorensen et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Synergistic antitumour effects of rapamycin and oncolytic reovirus
Charles Comins et al.
CANCER GENE THERAPY (2018)
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka et al.
CLINICAL CANCER RESEARCH (2018)
Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
Pavlos Msaouel et al.
CURRENT CANCER DRUG TARGETS (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
Cheyne Kurokawa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells
Cole Peters et al.
JOURNAL OF VIROLOGY (2018)
Autophagy during viral infection - a double-edged sword
Younho Choi et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Mechanism and medical implications of mammalian autophagy
Ivan Dikic et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Durable complete responses in some recurrent highgrade glioma patients treated with Toca 511+Toca FC
Timothy F. Cloughesy et al.
NEURO-ONCOLOGY (2018)
Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment
Wouter B. L. van den Bossche et al.
NEURO-ONCOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Adel Samson et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A hypoxia- and telomeraseresponsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma
Eonju Oh et al.
SCIENTIFIC REPORTS (2018)
Autophagy in Negative-Strand RNA Virus Infection
Yupeng Wang et al.
FRONTIERS IN MICROBIOLOGY (2018)
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
Cheyne Kurokawa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Brain-Resident Microglia and Blood-Borne Macrophages Orchestrate Central Nervous System Inflammation in Neurodegenerative Disorders and Brain Cancer
Lisa Sevenich
FRONTIERS IN IMMUNOLOGY (2018)
The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes
Valeria Caneparo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Krijn K. Dijkstra et al.
CELL (2018)
Oncolytic herpes simplex virus and immunotherapy
Wenqing Ma et al.
BMC IMMUNOLOGY (2018)
Selective Autophagy and Xenophagy in Infection and Disease
Vartika Sharma et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
Chase Burton et al.
ONCOLYTIC VIROTHERAPY (2018)
TMIC-14. TUMOR EVOLUTION OF GLIOMA INTRINSIC GENE EXPRESSION SUBTYPE ASSOCIATES WITH IMMUNOLOGICAL CHANGES IN THE MICROENVIRONMENT
Qianghu Wang et al.
NEURO-ONCOLOGY (2017)
Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment
Nam Hee Lee et al.
ONCOTARGET (2017)
Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
David E. Cohn et al.
GYNECOLOGIC ONCOLOGY (2017)
Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer
Hiroshi Tazawa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma
Bingbing Dai et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky et al.
MOLECULAR THERAPY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Herpesvirus and Autophagy: All Right, Everybody Be Cool, This Is a Robbery!
Marion Lussignol et al.
VIRUSES-BASEL (2017)
Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth
Yu Shi et al.
NATURE COMMUNICATIONS (2017)
Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo
Yun-Ju Lai et al.
ONCOTARGET (2017)
Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma
Spyros Darmanis et al.
CELL REPORTS (2017)
Targeting Autophagy for Oncolytic Immunotherapy
Lulu Hu et al.
BIOMEDICINES (2017)
Vascular, glial, and lymphatic immune gateways of the central nervous system
Britta Engelhardt et al.
ACTA NEUROPATHOLOGICA (2016)
Dendritic cells in brain diseases
Peter Ludewig et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Cell of origin of glioma: biological and clinical implications
Sheila R. Alcantara Llaguno et al.
BRITISH JOURNAL OF CANCER (2016)
Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus
Kristian Taipale et al.
MOLECULAR THERAPY (2016)
The role of microglia and macrophages in glioma maintenance and progression
Dolores Hambardzumyan et al.
NATURE NEUROSCIENCE (2016)
The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein
Liang-Tzung Lin et al.
VIRUSES-BASEL (2016)
Measles Virus Host Invasion and Pathogenesis
Brigitta M. Laksono et al.
VIRUSES-BASEL (2016)
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial
Kevin J. Harrington et al.
ONCOTARGETS AND THERAPY (2016)
Recent advances in oncolytic adenovirus therapies for cancer
Amanda Rosewell Shaw et al.
CURRENT OPINION IN VIROLOGY (2016)
A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells
A. Kleijn et al.
STEM CELLS INTERNATIONAL (2016)
A Randomized Phase II study of Reolysin in Patients with Previously Treated Advanced or Metatstatic Non Small Cell Lung Cancer (NSCLC) receiving Standard Salvage Chemotherapy- Canadian Cancer Trials Group IND 211.
Donald Morris et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Molecular and Genomic Alterations in Glioblastoma Multiforme
Ines Crespo et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells
L. M. E. Berghauser Pont et al.
GENE THERAPY (2015)
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Helen M. Lazear et al.
IMMUNITY (2015)
Positive Feedback Regulation of Type I IFN Production by the IFN-Inducible DNA Sensor cGAS
Feng Ma et al.
JOURNAL OF IMMUNOLOGY (2015)
Confocal Imaging-Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study
Heidy Sierra et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Wenchao Zhou et al.
NATURE CELL BIOLOGY (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Oncolytic Replication of E1b-Deleted Adenoviruses
Pei-Hsin Cheng et al.
VIRUSES-BASEL (2015)
Going viral: a review of replication-selective oncolytic adenoviruses
Christopher Larson et al.
ONCOTARGET (2015)
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
Ilkka Liikanen et al.
ONCOIMMUNOLOGY (2015)
STING: infection, inflammation and cancer
Glen N. Barber
NATURE REVIEWS IMMUNOLOGY (2015)
Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells
Ke Jiang et al.
BMC CANCER (2014)
The Nogo Receptor NgR1 Mediates Infection by Mammalian Reovirus
Jennifer L. Konopka-Anstadt et al.
CELL HOST & MICROBE (2014)
Antiviral Autophagy Restricts Rift Valley Fever Virus Infection and Is Conserved from Flies to Mammals
Ryan H. Moy et al.
IMMUNITY (2014)
MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma
Brian J. Gill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
Jianfang Ning et al.
FRONTIERS IN MICROBIOLOGY (2014)
Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses
Andrew Zloza et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Activated Ras signaling pathways and reovirus oncolysis an update on the mechanism of preferential reovirus replication in cancer cells
Jun Gong et al.
FRONTIERS IN ONCOLOGY (2014)
OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids
Veit Hornung et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Advances in Oncolytic Virotherapy for Brain Tumors
Rutger K. Balvers et al.
GENE THERAPY OF CANCER: TRANSLATIONAL APPROACHES FROM PRECLINICAL STUDIES TO CLINICAL IMPLEMENTATION, 3RD EDITION (2014)
Heterogeneous reovirus susceptibility in human glioblastoma stem-like cell cultures
S. K. van den Hengel et al.
CANCER GENE THERAPY (2013)
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Lin Cheng et al.
CELL (2013)
Oncolytic measles virus strains have significant antitumor activity against glioma stem cells
C. Allen et al.
GENE THERAPY (2013)
Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis
Susanne Berchtold et al.
JOURNAL OF VIROLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Standards of care for treatment of recurrent glioblastoma-are we there yet?
Michael Weller et al.
NEURO-ONCOLOGY (2013)
Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrixassociated gene modules
Rutger K. Balvers et al.
NEURO-ONCOLOGY (2013)
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu-Emerson et al.
NEURO-ONCOLOGY (2013)
PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
Kelly L. Barton et al.
PLOS ONE (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells
Pei-Hsin Cheng et al.
VIROLOGY JOURNAL (2013)
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
Tiffany Doucette et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
Chunchun Meng et al.
ARCHIVES OF VIROLOGY (2012)
Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway
Katie Twigger et al.
BMC CANCER (2012)
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
Karsten Geletneky et al.
BMC CANCER (2012)
Preferential Replication of Systemically Delivered Oncolytic Vaccinia Virus in Focally Irradiated Glioma Xenografts
Sunil J. Advani et al.
CLINICAL CANCER RESEARCH (2012)
Molecular Pathways: Rodent Parvoviruses-Mechanisms of Oncolysis and Prospects for Clinical Cancer Treatment
Juerg P. F. Nueesch et al.
CLINICAL CANCER RESEARCH (2012)
Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
Omar D. Perez et al.
MOLECULAR THERAPY (2012)
C-type lectin receptors orchestrate antifungal immunity
Sarah E. Hardison et al.
NATURE IMMUNOLOGY (2012)
The anatomical and cellular basis of immune surveillance in the central nervous system
Richard M. Ransohoff et al.
NATURE REVIEWS IMMUNOLOGY (2012)
RETROVIRAL REPLICATING VECTORS IN CANCER
Christopher R. Logg et al.
METHODS IN ENZYMOLOGY, VOL 507: GENE TRANSFER VECTORS FOR CLINICAL APPLICATION (2012)
The Role of Atg Proteins in Autophagosome Formation
Noboru Mizushima et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Oncolytic poliovirus against malignant glioma
Christian Goetz et al.
FUTURE VIROLOGY (2011)
Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replication
Xinping Fu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Human MxA Protein: An Interferon-Induced Dynamin-Like GTPase with Broad Antiviral Activity
Otto Haller et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Oncolytic Specificity of Newcastle Disease Virus Is Mediated by Selectivity for Apoptosis-Resistant Cells
Mena Mansour et al.
JOURNAL OF VIROLOGY (2011)
Human Adenovirus Type 5 Induces Cell Lysis through Autophagy and Autophagy-Triggered Caspase Activity
Hong Jiang et al.
JOURNAL OF VIROLOGY (2011)
Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus
Ilkka Liikanen et al.
MOLECULAR THERAPY (2011)
Induction and function of type I and III interferon in response to viral infection
David E. Levy et al.
CURRENT OPINION IN VIROLOGY (2011)
Cyclin D as a therapeutic target in cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Autophagy Protects against Sindbis Virus Infection of the Central Nervous System
Anthony Orvedahl et al.
CELL HOST & MICROBE (2010)
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Nicholas S. Heaton et al.
CELL HOST & MICROBE (2010)
IFI16 is an innate immune sensor for intracellular DNA
Leonie Unterholzner et al.
NATURE IMMUNOLOGY (2010)
Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus
J. Puhlmann et al.
ONCOGENE (2010)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil N. Senzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses
Dmitriy Zamarin et al.
MOLECULAR THERAPY (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas
Amy B. Heimberger et al.
CLINICAL CANCER RESEARCH (2008)
Recombinant Oncolytic Poliovirus Eliminates Glioma In Vivo Without Genetic Adaptation to a Pathogenic Phenotype
Elena Y. Dobrikova et al.
MOLECULAR THERAPY (2008)
Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death
Marta M. Alonso et al.
MOLECULAR THERAPY (2008)
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas
Peter Forsyth et al.
MOLECULAR THERAPY (2008)
Interferon-inducible antiviral effectors
Anthony J. Sadler et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Differential effects of combined Ad5-Δ24RGD and radiation therapy in In vitro versus In vivo models of malignant glioma
Martine L. M. Lamfers et al.
CLINICAL CANCER RESEARCH (2007)
Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release
Paola Marcato et al.
MOLECULAR THERAPY (2007)
Proteolytic disassembly is a critical determinant for reovirus oncolysis
Tommy Alain et al.
MOLECULAR THERAPY (2007)
Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4
Dawn E. Post et al.
CANCER RESEARCH (2007)
Comparative evaluation of survivin, midkine, and CXCR4 promoters for transcriptional targeting of glioma gene therapy
Ilya V. Ulasov et al.
CANCER BIOLOGY & THERAPY (2007)
Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells
Matteo Di Piazza et al.
JOURNAL OF VIROLOGY (2007)
Autophagy-dependent viral recognition by plasmacytoid dendritic cells
Heung Kyu Lee et al.
SCIENCE (2007)
Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells
Marianne M. Stanford et al.
JOURNAL OF VIROLOGY (2007)
Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli
Dennis Hoffmann et al.
BMC BIOTECHNOLOGY (2006)
Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines
Sateesh Krishnamurthy et al.
JOURNAL OF VIROLOGY (2006)
CD46 represents a target for adenoviral gene therapy of malignant glioma
Ilya V. Ulasov et al.
HUMAN GENE THERAPY (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells
H Liao et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Reovirus oncolysis: The Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection
KL Norman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
EA Chiocca et al.
MOLECULAR THERAPY (2004)
The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro
J Grill et al.
MOLECULAR THERAPY (2002)
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study
V Papanastassiou et al.
GENE THERAPY (2002)
Intergeneric poliovirus recombinants for the treatment of malignant glioma
M Gromeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
